If potheads did not have enough good excuses for getting high, editors at the British Journal of Pharmacology just gave them a fresh one.

According to an article in EurekAlert, the British Journal has a review looking at the likelihood that a particular cannabinoid — one of many compounds found in marijuana — has the potential to treat cancer.

The type of cannabinoid under examination, phytocannabinoid, has been shown to “stop cancer cells from dividing and invading normal tissue, and they may block the blood supply in tumors.”

Additionally, the review found that this weed compound may be able to “enhance the body’s immune response against the growth and spread of tumors.”

Professor Burkhard Hinz, of Rostock University Medical Center in Germany, authored the study and is high on pot’s potential. He told EurekAlert that this should ignite more research on the topic: “Clinical studies are now urgently needed to investigate the impact of cannabinoids on cancer growth and progression in patients.”